Literature DB >> 6644837

Thyrotoxicosis in the elderly.

M J Finch, D Woodbury.   

Abstract

Charts of 28 hyperthyroid patients over 60 years old were retrospectively analyzed and compared with charts of 14 patients under 30 years old. The mean duration of symptoms prior to diagnosis was 16 months in the elderly and five months in the younger group. Heart rate was substantially lower in the older (107 beats/min) vs younger (117 beats/min) study group. The symptom of weakness or fatigue was more prevalent in the elderly group (94 percent) than in the younger group (57 percent). Cardiac palpitation was more prevalent in the elderly patients whereas insomnia, irritability, dysphagia, hyperphagia, and heat intolerance were more prevalent in the younger patients. Fifty percent of the elderly patients complained of chest pain. Cachexia (62 percent), thin, fine hair (50 percent), and weakness (58 percent) were prominent physical findings in the elderly group. Twenty-six percent of the elderly patients had atrial fibrillation. These findings confirm previous studies that show some differences in presentation of hyperthyroidism in elderly patients when compared with younger patients. The authors recommend that thyroid function tests be obtained for broad indications in the elderly.

Entities:  

Mesh:

Year:  1983        PMID: 6644837      PMCID: PMC2561603     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

Review 1.  Impaired peripheral conversion of thyroxine to triiodothyronine,.

Authors:  R R Cavalieri
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

2.  Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients.

Authors:  P J Davis; F B Davis
Journal:  Medicine (Baltimore)       Date:  1974-05       Impact factor: 1.889

3.  Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.

Authors:  J C Forfar; H C Miller; A D Toft
Journal:  Am J Cardiol       Date:  1979-07       Impact factor: 2.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.